ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Agostino, R. S.
Right arrow Articles by Shumway, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Agostino, R. S.
Right arrow Articles by Shumway, N. E.

The Annals of Thoracic Surgery, Vol 40, 429-438, Copyright © 1985 by The Society of Thoracic Surgeons


ARTICLES

Valve replacement in patients with native valve endocarditis: what really determines operative outcome?

RS D'Agostino, DC Miller, EB Stinson, RS Mitchell, PE Oyer, SW Jamieson, JC Baldwin and NE Shumway

The influence of 27 variables on operative mortality and late complications (defined as residual or recurrent endocarditis or late bland periprosthetic leak) was determined using discriminant analysis for 108 patients undergoing valve replacement for native valve endocarditis at Stanford University Medical Center from March, 1964, to January, 1983. Congestive heart failure was the indication for valve replacement in 86% of patients. Aortic valve replacement was required in 68% and mitral valve replacement, in 26%. Patients were arbitrarily defined as having active (58%) or healed (42%) endocarditis. Follow-up included 515 patient-years and extended to a maximum of 19 years. Operative mortality was 15 +/- 4%, and 17 patients had late complications (linearized rate, 3.3% per patient-year). Seven variables were significantly related to operative mortality in the univariate analysis, but only organism (Staphylococcus aureus versus all others, p = 0.0302) was a significant independent predictor of operative mortality. For late complications, only 2 of 7 significant univariate covariates proved to be significant independent determinants: organisms on valve culture or gram stain and the presence of annular abscess. Patients with S. aureus endocarditis not showing prompt response to antibiotic treatment must be considered for early operation. Similarly, timely operative intervention for patients with annular abscess will be essential in decreasing late valve infections and perivalvular leaks.


This article has been cited by other articles:


Home page
ICVTSHome page
F. Farhat, M. Durand, F. Delahaye, and O. Jegaden
Prosthetic valve sewing-ring sealing with antibiotic and fibrin glue in infective endocarditis. A prospective clinical study
Interactive CardioVascular and Thoracic Surgery, February 1, 2007; 6(1): 16 - 20.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Revilla, J. Lopez, I. Vilacosta, E. Villacorta, M. J. Rollan, J. R. Echevarria, Y. Carrascal, S. Di Stefano, E. Fulquet, E. Rodriguez, et al.
Clinical and prognostic profile of patients with infective endocarditis who need urgent surgery
Eur. Heart J., January 1, 2007; 28(1): 65 - 71.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
K.-L. Chan
Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess
Can. Med. Assoc. J., July 1, 2002; 167(1): 19 - 24.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J M Guerra, M P Tornos, G Permanyer-Miralda, B Almirante, M Murtra, and J Soler-Soler
Long term results of mechanical prostheses for treatment of active infective endocarditis
Heart, July 1, 2001; 86(1): 63 - 68.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. R. Moon, D. C. Miller, K. A. Moore, P. E. Oyer, R. S. Mitchell, R. C. Robbins, E. B. Stinson, N. E. Shumway, and B. A. Reitz
Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis
Ann. Thorac. Surg., April 1, 2001; 71(4): 1164 - 1171.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Alexiou, S. M. Langley, H. Stafford, J. A. Lowes, S. A. Livesey, and J. L. Monro
Surgery for active culture-positive endocarditis: determinants of early and late outcome
Ann. Thorac. Surg., May 1, 2000; 69(5): 1448 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Genoni, D. Franzen, P. Vogt, B. Seifert, R. Jenni, A. Kunzli, U. Niederhauser, and M. Turina
Paravalvular leakage after mitral valve replacement: improved long-term survival with aggressive surgery?
Eur. J. Cardiothorac. Surg., January 1, 2000; 17(1): 14 - 19.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. B. Rosen, V. G. Fowler Jr., G. R. Corey, S. M. Downs, A. K. Biddle, J. Li, and J. G. Jollis
Cost-Effectiveness of Transesophageal Echocardiography To Determine the Duration of Therapy for Intravascular Catheter-Associated Staphylococcus aureus Bacteremia
Ann Intern Med, May 18, 1999; 130(10): 810 - 820.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Choussat, D. Thomas, R. Isnard, P.-L. Michel, B. Iung, G. Hanania, P. Mathieu, M. David, T. du Roy de Chaumaray, G. De Gevigney, et al.
Perivalvular abscesses associated with endocarditis: Clinical features and prognostic factors of overall survival in a series of 233 cases
Eur. Heart J., February 1, 1999; 20(3): 232 - 241.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. M. Lee, L. M. Shapiro, and F. C. Wells
Conservative Operation for Infective Endocarditis of the Mitral Valve
Ann. Thorac. Surg., April 1, 1998; 65(4): 1087 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Bauernschmitt, H. G. Jakob, C.-F. Vahl, R. Lange, and S. Hagl
Operation for Infective Endocarditis: Results After Implantation of Mechanical Valves
Ann. Thorac. Surg., February 1, 1998; 65(2): 359 - 364.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. D. Muehrcke, D. M. Cosgrove III, B. W. Lytle, P. C. Taylor, A. M. Burgar, C. P. Durnwald, and F. D. Loop
Is There an Advantage to Repairing Infected Mitral Valves?
Ann. Thorac. Surg., June 1, 1997; 63(6): 1718 - 1724.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
Y. d'Udekem, T. E. David, C. M. Feindel, S. Armstrong, and Z. Sun
Long-Term Results of Operation for Paravalvular Abscess
Ann. Thorac. Surg., July 1, 1996; 62(1): 48 - 53.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Eishi, K. Kawazoe, Y. Kuriyama, Y. Kitoh, Y. Kawashima, and T. Omae
SURGICAL MANAGEMENT OF INFECTIVE ENDOCARDITIS ASSOCIATED WITH CEREBRAL COMPLICATIONSMulti-center retrospective study in Japan
J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1745 - 1755.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Watanabe, A. Haverich, R. Speier, C. Dresler, and H. G. Borst
Surgical treatment of active infective endocarditis with paravalvular involvement
J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 171 - 177.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1985 by The Society of Thoracic Surgeons.